Developed the global commercialization strategy of a potential cardiovascular blockbuster product and steered the launch in Europe and North America
Developed the launch strategy during the pre-launch phase of Valsartan (Diovan), a new generation cardiovascular product that reached block-buster status at peak
Broad track record with +25 years´ of international experience in the pharmaceutical industry (B2B, B2C)
Demonstrated operational & commercial leadership skills as VP/Head of Europe, General Manager DACH, Business Development & Alliance Management
Strategic and tactical executive and leader who inspires people towards a clear vision, change and focused goals
Strong interpersonal skills and intercultural competence
Entdecken Sie andere Experten mit ähnlichen Qualifikationen und Erfahrungen.